Latest Erasmus University Rotterdam Stories
CAMBRIDGE, Mass., April 30, 2013 /PRNewswire/ -- Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics(TM)--a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins--announced today that Henri A. Termeer, Genzyme's retired chairman, president, and CEO, has joined Moderna's board of directors. Over nearly 30 years at Genzyme, Termeer built one of the world's most innovative and commercially successful biotechnology...
ROTTERDAM, The Netherlands, October 4, 2012 /PRNewswire/ -- Viroclinics Biosciences B.V. has relocated to the Rotterdam Science Tower, a new high-tech science facility that's about to become a hotspot for international life sciences, medical innovations and spin-offs from Erasmus MC and Erasmus University Rotterdam. This location will form the core of a powerful cluster of biomedical businesses, bringing a vast range of medical knowledge and business activity together within a...
GRONINGEN, The Netherlands, July 4, 2012 /PRNewswire/ -- Dr. Cees de Jong (former COO Crucell) appointed Chairman of the Board. Ms. Annemieke Wouterse (N.O.M.) appointed member of the board. Polyganics today announced the following appointments: Dr. Cees de Jong (1961) joins Polyganics Supervisory Board to act as Chairman. Mr. De Jong was the Chief Operating Officer and a member of the Management Board of Dutch Biotechnology company Crucell till its...
REDWOOD CITY, Calif., Jan. 18, 2011 /PRNewswire/ -- Ingenuity® Systems, a leading provider of information solutions for life science researchers, and Erasmus Medical Center, jointly announced a scientific collaboration using next-generation sequencing (NGS) for disease research. As part of the collaboration, Erasmus researchers have been working closely with Ingenuity to derive the most impactful biological insights from their NGS data. Using Ingenuity's IPA software and the...
A study has found that people in low and middle-income countries would be pushed to below the poverty line if they bought common medicines. Laurens Niens' team at Erasmus University Rotterdam analyzed the number of people who would be pushed below an income level of $1.25 or $2 a day by paying for four widely used medicines. The team said their findings showed that greater effort is needed in order to encourage the use of cheaper generic drugs in poor countries to help ensure more medicines...
Three new genetic loci have been identified with involvement in subtle and quantitative variation of human eye color. The study, led by Manfred Kayser of the Erasmus University Medical Center Rotterdam, The Netherlands, was published May 6 in the open-access journal PLoS Genetics.Previous studies on the genetics of human eye color used broadly-categorized trait information such as 'blue', 'green', and 'brown'; however, variation in eye color exists in a continuous grading from the lightest...
For the fifth time, ESA hosted this month the one-week CEMS kick-off seminar for students from leading European management schools to learn about technology transfer and what it takes to turn space technology breakthroughs into viable non-space businesses.Organized by ESA's Technology Transfer Program Office in cooperation with ESA Human Spaceflight's Erasmus Center as well as the Rotterdam School of Management Erasmus University (RSM), the Community of European Management Schools (CEMS)...
Vnus Medical Technologies, a provider of medical devices for the minimally invasive treatment of venous reflux disease, has appointed Guido Smeets as its new vice president of clinical research and chief medical officer. Prior to joining Vnus, Dr Smeets served as the head of clinical affairs for Pelikan Technologies, a privately held diagnostic testing platform company. Dr Smeets holds a doctor of medicine from Utrecht University, School of Medicine, The Netherlands and an MBA from Erasmus...
